UpToDate Lexidrug is a professional-grade drug reference app providing clinical monographs, interaction checkers, and medical calculators for healthcare providers.
Product velocity
Maintenance
Daily rank 🇺🇸
#169
▼13Medical · free
Sentiment
4.2
8k reviews
Nemesis
Drugs.com Medication Guide
The App DNA
What makes this app unique?
Clinicians hire this tool for evidence-based, offline-accessible drug information that ensures patient safety during point-of-care decisions.
For Healthcare professionals including pharmacists, physicians, nurses, and students requiring evidence-based drug information.
What does it look like?
Key features
Interactive tool to identify potential adverse reactions between multiple medications
Ability to store drug monographs and clinical content locally on the device
Integrated suite of hundreds of clinical calculators for dosing and therapeutic support
Clinical information reviewed and updated daily by an internal editorial team
How much does it cost?
Subscription model anchored at $29.99/month, targeting professional users with a 14-day trial conversion funnel.
Velocity
Maintenance developmentperformanceUX improvementsShow more...
The app maintains a maintenance-level cadence, shipping approximately 0.15 releases per week over the last six months. Development is characterized by infrequent, minor updates focused primarily on stability and performance rather than new feature delivery. The most recent major feature addition occurred in February 2026, with subsequent releases providing only generic bug fixes and small enhancements. There is no evidence of live-ops activity or a high-frequency release cycle.
Who built it?
User Sentiment
What do users think recently?
Recent user voice shows a frustrated sentiment. Users appreciate reliable clinical reference content remains a daily essential for medical professionals in clinical settings, but report persistent database download failures prevent access to critical drug interactions and compatibility information.
How are ratings & reviews evolving?
What users say, by theme
- Reliable clinical reference content remains a daily essential for medical professionals in clinical settings
- Persistent database download failures prevent access to critical drug interactions and compatibility information
66 of 106 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for UpToDate Lexidrug
How's the Medical market?
UpToDate Lexidrug holds a #17 Grossing position in the US Medical category, reflecting strong professional monetisation despite a high-friction UI. The gap between its high-value clinical content and the recent technical instability creates a vulnerability to niche competitors.
Read the market outlookThe rivals identified
By Drugs.com
With over 36,000 reviews and a high-velocity release cadence, this app dominates the general-purpose drug reference market.
- Offers a massive, free-to-access consumer-facing database that captures broader search intent than professional-only tools.
- Maintains a high release frequency of 6 updates in six months, ensuring rapid adaptation to platform changes.
- Provides a comprehensive pill identification tool integrated directly into the core medication guide experience.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for UpToDate Lexidrug
Where is it heading?
The professional medical reference market is consolidating around tools that provide high-speed, reliable point-of-care access. UpToDate Lexidrug's current technical instability and UI friction leave it exposed to niche competitors, so the team must shift from feature-parity to stability-first engineering to prevent further subscription loss.
- Persistent database download failures prevent access to critical clinical data, which directly causes professional churn to more stable competitors.
- UI navigation changes hide essential tools behind excessive menus, slowing down point-of-care workflows and reducing daily active usage.
The SWOT
- Daily editorial updates establish clinical authority
- Offline database access creates high switching costs
- Expand B2B institutional partnerships
- Integrate calculators into monograph view
Next best moves
Rebuild database download logic because download failures are the #1 complaint → restore core clinical utility
+ 1 more prioritized moveThe counter-intuitive read
The app's biggest risk is not a competitor feature…
Read the full takeFeature gaps
Real-time pill identification (available in Drugs.com but missing here) +1
Since the last report: The app's competitive position is weakening due to technical instability and UI navigation regressions that hinder professional workflows.
Bottom line
UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated